Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 7, 2026 07:00AM
Mar 18, 2026 05:19AM
Mar 17, 2026 05:13PM
Mar 17, 2026 04:01PM
Mar 17, 2026 04:01PM Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
Mar 6, 2026 04:01PM
Mar 6, 2026 04:01PM
Mar 2, 2026 08:32AM
Mar 2, 2026 08:30AM
Feb 26, 2026 04:25PM
Feb 26, 2026 07:00AM
Jan 2, 2026 08:00AM Lantheus completes sale of SPECT business to SHINE Technologies
Jan 2, 2026 08:00AM
Nov 6, 2025 07:02AM
Nov 6, 2025 07:00AM
Oct 30, 2025 08:31AM
Oct 30, 2025 08:30AM
Oct 28, 2025 08:33AM
Oct 28, 2025 08:30AM Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
Sep 24, 2025 04:51AM
Sep 24, 2025 01:00AM
Sep 11, 2025 08:14AM
Aug 6, 2025 07:00AM
Aug 6, 2025 06:45AM
Aug 6, 2025 06:45AM
Jul 22, 2025 09:13AM Lantheus completes Life Molecular Imaging acquisition, names new R&D head
Jul 22, 2025 08:55AM
Jul 22, 2025 07:00AM
Jul 22, 2025 07:00AM
Jun 11, 2025 04:01PM
May 7, 2025 07:00AM
May 6, 2025 04:01PM
May 6, 2025 04:01PM Lantheus Announces Sale of SPECT Business to SHINE Technologies
Apr 30, 2025 08:30AM
Apr 30, 2025 08:30AM
Feb 26, 2025 07:00AM
Feb 15, 2025 10:00PM
Feb 5, 2025 08:30AM
Jan 28, 2025 06:15AM
Jan 28, 2025 06:00AM Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
Nov 11, 2024 07:41AM
Nov 11, 2024 07:39AM
Nov 6, 2024 07:00AM
Nov 4, 2024 07:30AM
Sep 30, 2024 03:11PM
Sep 15, 2024 08:45AM
Aug 20, 2024 08:30AM Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
Jul 31, 2024 07:00AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All